An Ottawa-based hemp firm has raised a sizeable chunk of funding to improve its U.S. production prospects.
LiveWell Canada announced this week it had closed a private placement of senior secured convertible notes worth $15 million. Some $3 million of these notes include previously announced bridge financing to cover costs related to its anticipated merger with Canada’s Vitality CBD Natural Health Products and its U.S. subsidiary. (All figures in USD.)
The firm also closed a placement of equity units, raising a total of C$1.7 million (US$1.3 million). Factoring in agent fees and legal expenses, LiveWell will collect roughly $12.1 million in net proceeds from the rounds.
(Sponsored)
Invest with confidence: Hydro Ottawa funds technical studies for business retrofits
For Ottawa businesses, the opportunity to improve building performance has never been greater. Energy retrofits can cut emissions, strengthen operations, extend the life of assets, reduce operating costs, and position
In a tough economy, investing in community is more important than ever
When finances are tight, it might seem counterintuitive to give back, but supporting our most vulnerable neighbours this holiday season can actually help businesses weather their own challenges. At United
LiveWell develops products from extracted CBD, the non-psychoactive component of cannabis. The company said in a release it will put the net proceeds from its raise towards enhancing and optimizing production at an extraction facility in Eureka, MO, which it will acquire in the deal with Vitality. The acquisition remains subject to a shareholder vote, currently slated for April 11.
